MedPath

Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy

Not Applicable
Completed
Conditions
Pancreatic Cancer
Pancreatic Surgery
Registration Number
NCT01059097
Lead Sponsor
Università Vita-Salute San Raffaele
Brief Summary

The independent impact of surgeon volume on outcome of patients undergoing pancreaticoduodenectomy in a high-volume Institution was assessed. A significant reduction of pancreatic fistula rate was found in the high-volume surgeon group in comparison with low-volume surgeon group. However, no difference between groups was found in mortality, major complications, and hospital stay.

Detailed Description

Objectives: To define the independent impact of surgeon volume on outcome after pancreaticoduodenectomy (PD) in a single high-volume institution.

Summary Background Data: The impact of surgeon volume on PD outcome is still controversial. So far, data available are from retrospective multi-institutional reviews, considering in-hospital mortality as the only outcome variable.

Methods: Prospectively collected data on 610 patients who underwent PD from August 2001 to August 2009 were analyzed. Cut-off value to categorize high and low-volume surgeons (HVS and LVS, respectively) was 18 PD/year. Primary endpoint was operative mortality (death within 30-day post-discharge). Secondary endpoints were morbidity, pancreatic fistula (PF) and length of stay. Demographic, clinical, and surgical variables were recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
610
Inclusion Criteria
  • Patients who underwent pancreaticoduodenectomy between August 2001 and August 2009
Exclusion Criteria
  • Other type of surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Postoperative mortality after pancreaticoduodenectomy within 30 days of discharge30 days after discharge
Secondary Outcome Measures
NameTimeMethod
Postoperative morbidity rate measuring the following complications: pancreatic fistula, biliary fistula, delayed gastric emptying, infectious complications, bleeding, cardiovascular complications, respiratory complications.30 days post-discharge
Postoperative hospital stay. Measuring the length of hospital stay.At day of discharge

Trial Locations

Locations (1)

San Raffaele Scientific Institute

🇮🇹

Milan, MI, Italy

San Raffaele Scientific Institute
🇮🇹Milan, MI, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.